Enhancing type 2 diabetes treatment through digital plans of care. First results from the East Cheshire Study of an App to support people in the management of type 2 diabetes.
Adrian H Heald, Lucia Albeda Gimeno, Erin Gilingham, Lynne Hudson, Lisa Price, Anuj Saboo, Laura Beresford, Sally Seviour, Alison White, Sarah Roberts, Jonathan Abraham
{"title":"Enhancing type 2 diabetes treatment through digital plans of care. First results from the East Cheshire Study of an App to support people in the management of type 2 diabetes.","authors":"Adrian H Heald, Lucia Albeda Gimeno, Erin Gilingham, Lynne Hudson, Lisa Price, Anuj Saboo, Laura Beresford, Sally Seviour, Alison White, Sarah Roberts, Jonathan Abraham","doi":"10.1097/XCE.0000000000000268","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The use of personalised care planning has been effective at improving health outcomes for people with long-term health conditions.</p><p><strong>Methods: </strong>We analysed data in relation to changes in BMI/HbA1c. The sample was made up of (<i>n</i> = 36) participants randomised to either the active intervention group (App+usual care) or the control group (usual care).</p><p><strong>Results: </strong>The average HbA1c percentage change for the treatment group was 9.5%, but just -2% for the control (usual care) group (<i>P</i> = 0.015 for the difference). The average percentage change in BMI for the treatment group was -0.4%, but 0.1% for the control group (<i>P</i> = 0.03 for the difference).</p><p><strong>Conclusion: </strong>These preliminary findings point to how the provision of personalised plans of care, support and education linked to a mobile app, can result in HbA1c and BMI reduction over a 6-month period. While the results are preliminary, they portend the potential for digital plans of care to enhance T2DM management.</p>","PeriodicalId":43231,"journal":{"name":"Cardiovascular Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/0d/xce-11-e0268.PMC9298469.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/XCE.0000000000000268","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 2
Abstract
Introduction: The use of personalised care planning has been effective at improving health outcomes for people with long-term health conditions.
Methods: We analysed data in relation to changes in BMI/HbA1c. The sample was made up of (n = 36) participants randomised to either the active intervention group (App+usual care) or the control group (usual care).
Results: The average HbA1c percentage change for the treatment group was 9.5%, but just -2% for the control (usual care) group (P = 0.015 for the difference). The average percentage change in BMI for the treatment group was -0.4%, but 0.1% for the control group (P = 0.03 for the difference).
Conclusion: These preliminary findings point to how the provision of personalised plans of care, support and education linked to a mobile app, can result in HbA1c and BMI reduction over a 6-month period. While the results are preliminary, they portend the potential for digital plans of care to enhance T2DM management.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
